Publications by authors named "Kirk Tanner"

Claim this Profile
I
Identifying appropriate external control datasets in support of future glioblastoma clinical trials leveraging external data.
Rifaquat Rahman, Steffen Ventz, Robert Redd, Geoffrey Fell, Yujue Tan, Kirk Tanner

Neuro Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brave new framework for glioma drug development.
Kelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, Marjolein Geurts, Timothy F Cloughesy, Kirk Tanner

Lancet Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology.
Rifaquat Rahman, Diana D Shi, Zachary J Reitman, Petra Hamerlik, John F de Groot, Kirk Tanner

Neuro Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
Kirit Singh, Kelly M Hotchkiss, Ian F Parney, John De Groot, Solmaz Sahebjam, Kirk Tanner

Nat Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.
Michelle M Kim, Minesh P Mehta, DeeDee K Smart, Patricia S Steeg, Julie A Hong, Kirk Tanner

Lancet Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.
Benjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, Caroline Chung, Howard Colman, Kirk Tanner

Neuro Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of cancer immunotherapy for brain tumors: a collaborative workshop.
Christine E Brown, Samantha Bucktrout, Lisa H Butterfield, Olga Futer, Evanthia Galanis, Kirk Tanner

J Transl Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Rifaquat Rahman, Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes-Rivera, Kirk Tanner

Lancet Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating glioblastoma therapeutics via venture philanthropy.
Kien Wei Siah, Qingyang Xu, Kirk Tanner, Olga Futer, John J Frishkopf

Drug Discov Today· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice.
Yuan Qin, Anna Musket, Jianqun Kou, Johanna Preiszner, Barbara R Tschida, Kirk Tanner

Neurooncol Adv· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proof of Principle for Local Delivery of a c-Met Inhibitor.
Howard Li, Irina Kadiyala, Michael Briggs, Rebecca Shawgo, Karem Reda, Kirk Tanner

J Pharm Sci· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
Jennifer Johnson, Maria Libera Ascierto, Sandeep Mittal, David Newsome, Liang Kang, Kirk Tanner

J Transl Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3beta.
Michael Arnost, Al Pierce, Ernst ter Haar, David Lauffer, Jaren Madden, Kirk Tanner

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redox regulation of protein tyrosine phosphatases by hydrogen peroxide: detecting sulfenic acid intermediates and examining reversible inactivation.
John M Denu, Kirk G Tanner

Methods Enzymol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The acetyltransferase activity of CBP is required for wingless activation and H4 acetylation in Drosophila melanogaster.
William H Ludlam, Matthew H Taylor, Kirk G Tanner, John M Denu, Richard H Goodman

Mol Cell Biol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for the recognition of a bisphosphorylated MAP kinase peptide by human VHR protein Phosphatase.
Maria A Schumacher, Jacob L Todd, Adrian E Rice, Kirk G Tanner, John M Denu

Biochemistry· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis